Parent company Siemens said the IPO will consist of a secondary offering of shares from existing holdings of Siemens and is planned to post on the Regulated Market of the Frankfurt Stock Exchange.
Siemens Healthineers reported sales of $17 billion (EU €13.8 billion) for its fiscal year 2017, with more than 55% of sales logged as recurring.
“Siemens Healthineers is now ready for its market debut. Siemens Healthineers is a premium asset and we have worked hard to now list such an exciting franchise. We expect the business to capitalize on its strengths even more effectively after the listing,” Siemens Healthineers supervisory board chair Michael Sen said in a prepared statement.
Siemens said it plans to retain a majority stake in its Healthineers division in the long term.
“We are in a powerful place to shape the future of healthcare. Becoming a listed company will give us the increased freedom that we need to continue expanding our global leadership. With our Strategy 2025 we are ideally positioned to take advantage of the paradigm shifts in our industry and achieve even more growth,” Siemens Healthineers CEO Bernd Montag said in a press release.
Last month, Siemens Healthineers announced a multi-phase agreement with Florida Hospital to develop outcomes-based collaborative projects.
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Use code LASTCHANCE to save an additional 20%.